Childhood lymphoma

This entry looks childhood lymphoma. 'Lymphoma' is an umbrella term that loosely refers to several dozen independent categorical types and subtypes of cancers of the lymphatic system.

'Childhood lymphoma' by itself is not a diagnosis; rather, there are four major lymphoma subtypes that make up the category of childhood lymphoma, along with a number of less common subtypes that have been diagnosed in children.

The Four Major Subtypes of Childhood Lymphoma

The major subtypes are:

Burkitt (and Burkitt-like) B-cell non-Hodgkin's lymphoma
Burkitt's is one of the fastest-growing cancers known to medicine. Despite this—rather, on account of it—Burkitt's is treatable and often curable if caught early enough.

Diffuse large B-cell lymphoma
DLBCL is the most frequently diagnosed NHL among adults. It is treatable and, in some circumstances, curable.

Lymphoblastic lymphoma
LBL is now considered the same disease—morphologically and genetically—as acute lymphoblastic leukemia (ALL). This can affect either the T-cells or the B-cells.

Anaplastic large cell lymphoma
ALCL is an aggressive cancer that, unlike the previous three cancers, typically affects the T-cells, making it much more difficult to treat successfully.

Prognosis of Childhood Lymphoma

Prognosis for childhood lymphoma—and for any lymphoma, and for virtually any cancer—is highly dependent on a variety of factors, including:

  • -- Which lymphoma subtype is diagnosed
  • -- What stage the disease is in at diagnosis
  • -- The number of extra-lymphatic sites that are affected
  • -- The overall health of the patient
  • -- Whether the disease has reached the central nervous system

Sources

  • National Cancer Institute
  • Medscape reference
  • MacMillan Cancer Support

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap